Loading clinical trials...
Loading clinical trials...
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Conditions
Interventions
BEMA Buprenorphine NX films
Locations
10
United States
Birmingham, Alabama, United States
Haleyville, Alabama, United States
Jacksonville, Florida, United States
Maitland, Florida, United States
North Miami, Florida, United States
Prairie Village, Kansas, United States
Start Date
August 1, 2012
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
April 4, 2017
NCT05463367
NCT03345173
NCT04454411
NCT03842137
NCT06442306
NCT05995873
Lead Sponsor
BioDelivery Sciences International
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions